QIMING U.S. VENTURES MANAGEMENT, LLC
BELLEVUE, WA · CIK 1909617 · 13F filing filed 2025-11-10
Exempt reporting adviser since 2017 · limited liability company
- Private funds3 · $419.1m gross assets
- Main officeCambridge, MA
- Websiteqimingvcusa.com
- Form ADV · 2026-03-30SEC adviser record
- Kindventure
- Others nearbyCambridge, MA, San Francisco, CA, Bellevue, WA
As an employer
- Offices in1 country
- Private fundsventure capital 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Cambridge, MA (main office)United States | |
| Bellevue, WAUnited States | 2 |
| San Francisco, CAUnited States | 2 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$55.6m
reported value
+135.6% vs Q2 2025
4positions
100.0%in top 10
0 new
0 added
0 reduced
2 sold out
vs Q2 2025
Holdings, Q3 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| TOURMALINE BIO INC TRML | $35.5m63.76% | Unchanged |
| KORRO BIO INC KRRO | $17.6m31.68% | Unchanged |
| JASPER THERAPEUTICS INC JSPR | $2.2m3.97% | Unchanged |
| KEZAR LIFE SCIENCES INC KZR | $323.2k0.58% | Unchanged |
Sold out since Q2 2025
| Security | Value then |
|---|---|
| VENTYX BIOSCIENCES INC VTYX | $882.2k412.2k shares |
| HILLEVAX INC | $741.5k372.6k shares |